A novel action of palmitoyl-L-carnitine in human vascular endothelial cells

Journal of Pharmacological Sciences

Volumn 92, Issue 3, 2003, Pages 252-258

  Muraki, Katsuhiko ^a   Imaizumi, Yuji ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Calcium; EDG; Human vascular endothelial cell; Palmitoyl L carnitine; Sphingosine 1 phosphate

Indexed keywords

CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; PALMITOYLCARNITINE; PERTUSSIS TOXIN; SPHINGOSINE 1 PHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG SENSITIVITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR FLUID; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0043066788     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.252     Document Type: Article

References (27)

1. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984;55:135-154.
2. Netticadan T, Yu L, Dhalla NS, Panagia V. Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes. J Mol Cell Cardiol. 1999;31:1357-1367.
3. Mangin EL Jr, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 1993;72:161-166.
4. Inoue N, Hirata K, Yamada M, et al. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res. 1992;71:1410-1421.
5. Inoue N, Hirata K, Akita H, Yokoyama M. Palmitoyl-L-carnitine modifies the function of vascular endothelium. Cardiovasc Res. 1994;28:129-134.
6. Taki H, Muraki K, Imaizumi Y, Watanabe M. Mechanisms of the palmitoylcarnitine-induced response in vascular endothelial cells. Pflugers Arch. 1999;438:463-469.
7. Mutomba MC, Yuan H, Konyavko M, et al. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett. 2000;478:19-25.
8. Hla T, Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem. 1990;265:9308-9313.
9. Zondag GC, Postma FR, Etten IV, Verlaan I, Moolenaar WH. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. Biochem J. 1998;330:605-609.
10. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science. 1998;279:1552-1555.
11. Hla T, Lee MJ, Ancellin N, et al. Sphingosine-1-phosphate: Extracellular mediator or intracellular second messenger? Biochem Pharmacol. 1999;58:201-207.
12. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 1999;99:301-312.
13. Lee H, Goetzl EJ, An S. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol. 2000;278:C612-C618.
14. Muraki K, Imaizumi Y. A novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cells. J Physiol (Lond). 2001;537:431-441.
15. An S, Bleu T, Hallmark OG, Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem. 1998;273:7906-7910.
16. An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem Biophys Res Commun. 1997;231:619-622.
17. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J. 2000;349:385-402.
18. + current and hyperpolarization in human endothelial cells. Biochem Biophys Res Commun. 1997;236:340-343.
19. Murai T, Muraki K, Imaizumi Y, Watanabe M. Levcromakalim causes indirect endothelial hyperpolarization via a myo-endothelial pathway. Br J Pharmacol. 1999;128:1491-1496.
20. 2+-images of smooth muscle cells and endothelial cells in one confocal plane in femoral artery segments of the rat. Jpn J Pharmacol. 2001;86:106-113.
21. + channels by nordihydroguaiaretic acid. Jpn J Pharmacol. 2002;89:53-63.
22. Hill SJ, Ganellin CR, Timmerman H, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997;49:253-278.
23. Boss V, Wang X, Koppelman LF, Xu K, Murphy TJ. Histamine induces nuclear factor of activated T cell-mediated transcription and cyclosporin A-sensitive interleukin-8 mRNA expression in human umbilical vein endothelial cells. Mol Pharmacol. 1998;54:264-272.
24. Orlati S, Porcelli AM, Hrelia S, Rugolo M. Sphingosylphosphorylcholine and sphingosine-1-phosphate mobilize cytosolic calcium through different mechanisms in human airway epithelial cells. Cell Calcium. 1998;23:387-394.
25. Van Koppen C, Meyer Zu HM, Laser KT, et al. Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem. 1996;271:2082-2087.
26. Whitmer JT, Idell-Wenger JA, Rovetto MJ, Neely JR. Control of fatty acid metabolism in ischemic and hypoxic hearts. J Biol Chem. 1978;253:4305-4309.
27. Yatomi Y, Igarashi Y, Yang L, et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo). 1997;121:969-973.